Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells

Cell Proliferation

Volumn 46, Issue 2, 2013, Pages 127-136

  Poplineau, M ^a   Doliwa, C ^a   Schnekenburger, M ^b   Antonicelli, F ^a   Diederich, M ^b,c   Trussardi Regnier A ^a   Dufer, J ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GELATINASE A; GELATINASE B; TRICHOSTATIN A;

ARTICLE; CANCER GROWTH; CELLULAR PARAMETERS; CHROMATIN CONDENSATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; FIBROSARCOMA; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMAGE CYTOMETRY; METASTASIS; NUCLEAR TEXTURE; PROTEIN PROCESSING; SARCOMA CELL;

AZACITIDINE; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROSARCOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; IMAGE CYTOMETRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875347583     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12021     Document Type: Article

References (73)

1. Millot C, Dufer J (2000) Clinical applications of image cytometry to human tumour analysis. Histol. Histopathol. 15, 1185-1200.
2. Dey P (2010) Cancer nucleus: morphology and beyond. Diagn. Cytopathol. 38, 382-390.
3. Fafin-Lefevre M, Morlais F, Guittet L, Clin B, Launoy G, Galateau-Sallé F (2011) Nuclear morphology for the detection of alterations in bronchial cells from lung cancer: an attempt to improve sensitivity and specificity. Anal. Quant. Cytol. Histol. 33, 183-195.
4. Guillaud M, Le Riche JC, Dawe C, Korbelik J, Coldman A, Wistuba II et al. (2005) Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: correlation with genetic damage and cancer development. Cytometry A 63, 34-40.
5. Mello MLS, Vidal BC, Russo IH, Lareef MH, Russo J (2007) DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182, 780 as assessed by image analysis. Mutat. Res. 617, 1-7.
6. Trussardi-Regnier A, Lavenus S, Gorisse M-C, Dufer J (2009) Thalidomide alters nuclear architecture without ABCB1 gene modulation in drug-resistant myeloma cells. Int. J. Oncol. 35, 641-647.
7. De Campos Vidal B, Russo J, Mello ML (1998) DNA content and chromatin texture of benzo[a]pyrene-transformed human breast epithelial cells as assessed by image analysis. Exp. Cell Res. 244, 77-82.
8. Vaissière T, Sawan C, Herceg Z (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659, 40-48.
9. Mampumbu AR, Mello MLS (2006) DNA methylation in stingless bees with low and high heterochromatin contents as assessed by restriction enzyme digestion and image analysis. Cytometry A 69, 986-991.
10. Gertych A, Wawrowsky KA, Lindsley E, Vishnevsky E, Farkas DL, Tajbakhsh J. (2009) Automated quantification of DNA demethylation effects in cells via 3D mapping of nuclear signatures and population homogeneity assessment. Cytometry A 75, 569-583.
11. Gertych A, Farkas DL, Tajbakhsh J (2010) Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells. Exp. Cell Res. 316, 3150-3160.
12. El-Khoury V, Gomez D, Liautaud-Roger F, Trussardi-Régnier A, Dufer J (2004) Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells. Cytometry A 62, 109-117.
13. Toéth KF, Knoch TA, Wachsmuth M, Frank-Stöhr M, Stöhr M, Bacher CP et al. (2004) Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J. Cell Sci. 117, 4277-4287.
14. Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev. 22, 50-55.
15. Florean C, Schnekenburger M, Grandjenette C, Dicato M, Diederich M (2011) Epigenomics of leukemia: from mechanisms to therapeutic applications. Epigenomics 3, 581-609.
16. Schnekenburger M, Diederich M (2012) Epigenetics offer new horizons for colorectal cancer prevention. Curr. Colo. Cancer Rep. 8, 66-81.
17. Seidel C, Florean C, Schnekenburger M, Dicato M, Diederich M (2012) Chromatin-modifying agents in anti-cancer therapy. Biochimie 94, 2264-2279.
18. Seidel C, Schnekenburger M, Dicato M, Diederich M (2012) Histone deacetylase modulators provided by Mother Nature. Genes Nutr. 7, 357-367.
19. Folmer F, Orlikova B, Schnekenbuger M, Dicato M, Diederich M (2010) Naturally occurring regulators of histone acetylation/deacetylation. Curr. Nutr. Food Sci. 6, 78-99.
20. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
21. Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta. 1825, 29-36.
22. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS (2001) Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res. 7, 3113-3119.
23. Kondratiev S, Gnepp DR, Yakirevich E, Sabo E, Annino DJ, Rebeiz E et al. (2008) Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas. Hum. Pathol. 39, 337-343.
24. Diebold I, Petry A, Burger M, Hess J, Görlach A (2011) NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II. Mol. Biol. Cell 22, 4424-4434.
25. Niu D-F, Kondo T, Nakazawa T, Oishi N, Kawasaki T, Mochizuki K et al. (2012) Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas. Lab. Invest. 92, 1181-1190.
26. Takagi S, Simizu S, Osada H (2009) RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res. 69, 1502-1508.
27. Cock-Rada AM, Medjkane S, Janski N, Yousfi N, Perichon M, Chaussepied M et al. (2012) SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 72, 810-820.
28. Chernov AV, Strongin AY (2011) Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer. Biomol. Concepts 2, 135-147.
29. Cedar H, Bergman Y (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295-304.
30. Ikegami K, Ohgane J, Tanaka S, Yagi S, Shiota K (2009) Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. Int. J. Dev. Biol. 53, 203-214.
31. Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21, 103-107.
32. Doudkine A, Macaulay C, Poulin N, Palcic B (1995) Nuclear texture measurements in image cytometry. Pathologica 87, 286-299.
33. Giroud F, Gauvain C, Seigneurin D, Von Hagen V (1988) Chromatin texture changes related to proliferation and maturation in erythrocytes. Cytometry 9, 339-348.
34. Poplineau M, Dufer J, Antonicelli F, Trussardi-Regnier A (2011) Epigenetic regulation of proMMP-1 expression in the HT1080 human fibrosarcoma cell line. Int. J. Oncol. 38, 1713-1718.
35. Schnekenburger M, Grandjenette C, Ghelfi J, Karius T, Foliguet B, Dicato M et al. (2011) Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy. Biochem. Pharmacol. 81, 364-378.
36. Schneider CA, Rasband WS, Eliceiri CW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Meth. 9, 671-675.
37. Young IT (1977) Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25, 935-941.
38. Bartels PH, Da Silva VD, Montironi R, Hamilton PW, Thompson D, Vaught L et al. (1998) Chromatin texture signatures in nuclei from prostate lesions. Anal. Quant. Cytol. Histol. 20, 407-416.
39. Dufer J, Millot-Broglio C, Oum'Hamed Z, Liautaud-Roger F, Joly P, Desplaces A et al. (1995) Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines. Int. J. Cancer 60, 108-114.
40. Al-Nachawati H (1984) Segmentation multidimensionnelle. Stat. Anal. Données 9, 1-30.
41. Nielsen B, Albregtsen F, Danielsen HE (2008) Statistical nuclear texture analysis in cancer research: a review of methods and applications. Crit. Rev. Oncog. 14, 89-164.
42. Dunn JM, Hveem T, Pretorius M, Oukrif D, Nielsen B, Albregtsen F et al. (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. Br. J. Cancer 105, 1218-1223.
43. Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CP, De Souza CA et al. (2011) Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma. PLoS ONE 6, e20706.
44. Bedin V, Adam RL, De Sá BC, Landman G, Metze K (2010) Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. BMC Cancer 10, 260.
45. Huisman A, Ploeger LS, Dullens HFJ, Poulin N, Grizzle WE, Van Diest PJ (2005) Development of 3D chromatin texture analysis using confocal laser scanning microscopy. Cell. Oncol. 27, 335-345.
46. Wax A, Chalut KJ (2011) Nuclear morphology measurements with angle-resolved low coherence interferometry for application to cell biology and early cancer detection. Anal. Cell Pathol. (Amst) 34, 207-222.
47. Nandakumar V, Kelbauskas L, Johnson R, Meldrum D (2011) Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry. Cytometry A 79, 25-34.
48. Colomb E, Dussert C, Martin PM (1991) Nuclear texture parameters as discriminant factors in cell cycle and drug sensitivity studies. Cytometry 12, 15-25.
49. Poplineau M, Trussardi-Régnier A, Happillon T, Dufer J, Manfait M, Bernard P et al. (2011) Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. Epigenomics 3, 785-794.
50. Fudenberg G, Getz G, Meyerson M, Mirny LA (2011) High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat. Biotechnol. 29, 1109-1113.
51. Haaf T, Schmid M (2000) Experimental condensation inhibition in constitutive and facultative heterochromatin of mammalian chromosomes. Cytogenet. Cell Genet. 91, 113-123.
52. Kerr E, Kiyuna T, Boyle S, Saito A, Thomas JSJ, Bickmore WA (2010) Changes in chromatin structure during processing of wax-embedded tissue sections. Chromosome Res. 18, 677-688.
53. Berthe JV, Remmelink M, Werry J, Salmon I, Kiss R, Decaestecker C (2001) The contribution of image cytometry to the characterization of clinical subgroups of lipomas. Int. J. Oncol. 18, 1315-1321.
54. Pauwels O, Kiss R (1994) Computerized morphonuclear analyses of Feulgen-stained nuclei from 11 chemosensitive and from 11 chemoresistant neoplastic cell lines. Anal. Cell. Pathol. 7, 235-250.
55. Kotelnikov VM, Litinskaya LL (1981) Comparative studies of Feulgen hydrolysis for DNA. I. Influence of different fixatives and polyethylene glycols. Histochemistry 71, 145-153.
56. Gaub J (1976) Feulgen-Naphthol Yellow S cytophotometry of liver cells. The effect of formaldehyde induced shrinkage on nuclear Naphthol Yellow S binding. Histochemistry 49, 293-301.
57. Patties I, Jahns J, Hildebrandt G, Kortmann R-D, Glasow A (2009) Additive effects of 5-aza-2′-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines. Strahlenther. Onkol. 185, 331-338.
58. Haaf T (1995) The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes. Pharmacol. Ther. 65, 19-46.
59. De Mello MR, Albuquerque DM, Pereira-Cunha FG, Albanez KB, Pagnano KB, Costa FF et al. (2012) Molecular characteristics and chromatin texture features in acute promyelocytic leukemia. Diagn. Pathol. 7, 75.
60. Kalac M, Scotto L, Marchi E, Amengual J, Seshan VE, Bhagat G et al. (2011) HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. Blood 118, 5506-5516.
61. Watson JA, McKenna DJ, Maxwell P, Diamond J, Arthur K, McKelvey-Martin VJ et al. (2010) Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. J. Cell Mol. Med. 14, 1668-1682.
62. Hannen EJ, Van der Laak JA, Manni JJ, Pahlplatz MM, Freihofer HP, Slootweg PJ et al. (1998) An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue. J. Pathol. 185, 175-183.
63. Chik F, Szyf M (2011) Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis 32, 224-232.
64. Sato N, Maehara N, Su GH, Goggins M (2003) Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J. Natl. Cancer Inst. 95, 327-330.
65. Chicoine E, Estève P-O, Robledo O, Van Themsche C, Potworowski EF, St-Pierre Y (2002) Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem. Biophys. Res. Commun. 297, 765-772.
66. Couillard J, Demers M, Lavoie G, St-Pierre Y (2006) The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem. Biophys. Res. Commun. 342, 1233-1239.
67. Hagemann S, Heil O, Lyko F, Brueckner B (2011) Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS ONE 6, e17388.
68. Ailenberg M, Silverman M (2003) Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrosarcoma cells: implications for use of TSA in cancer therapy. Biochem. Biophys. Res. Commun. 302, 181-185.
69. Lee KH, Choi EY, Kim MK, Kim KO, Jang BI, Kim SW et al. (2010) Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer. Mol. Cell. Biochem. 343, 163-171.
70. Mitmaker EJ, Griff NJ, Grogan RH, Sarkar R, Kebebew E, Duh QY et al. (2011) Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. Surgery 149, 504-511.
71. Estella C, Herrer I, Atkinson SP, Quiñonero A, Martinez S, Pellicer A (2012) Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion. PLoS ONE 7, e30508.
72. Liu HB, Voso MT, Gumiero D, Duong J, McKendrick JJ, Dear AE (2009) The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression. Int. J. Oncol. 34, 573-579.
73. Citri A, Pang ZP, Südhof TC, Wernig M, Malenka RC (2012) Comprehensive qPCR profiling of gene expression in single neuronal cells. Nat. Protoc. 7, 118-127.